Community | September 23, 2010 | 0 comments

Gilenya gets FDA nod

source: http://www.buzztab.com/health-and-medicine/gilenya-gets-fda-nod/

Image
andycr43
Since starting on Gilenya more than two years ago, Labeling for Gilenya by FDA recommends that patients having their first dose of Gilenya should be kept under observation for six hours.

http://www.buzztab.com/health-and-medicine/gilenya-gets-fda-nod/
  1. groups:
    Community,   Body
  2. tags:
    Treatment,  Multiple Sclerosis,  Food and Drug Administration,  FDA Nod,  2 more
  3.     
    |

0 comments // Gilenya gets FDA nod

more from Community:
from the community

top videos